Literature DB >> 10829942

Chronic viral hepatitis.

M H Chang1.   

Abstract

Among hepatitis A to E viruses, hepatitis B, C, and D viruses can cause chronic hepatitis, in both children and adults. Hepatitis B virus (HBV) infection is the most prevalent and important one. Perinatal transmission accounts for about 40-45% of chronic HBV infection in hyperendemic areas. Horizontal transmission through intramuscular injection using non-sterile needles and intrafamilial spread accounts for the other half of carriers. During the natural course of HBV infection, the host gradually clears HBV and hepatitis B e antigen (HBeAg), liver damage and elevation of aminotransferases occur during the process of HBV clearance. The most effective way to eliminate HBV infection is immunoprophylaxis starting since birth. It can prevent both HBV and hepatitis D virus (HDV) infections. Hepatitis C virus (HCV) infection in children occurs mainly in high risk children, such as those who received blood product or injection using non-sterile needles, or infants of HCV viremic mothers, etc. Screening of blood product reduced markedly the prevalence of post-transfusion HCV infection, but the prevention of sporadic cases requires HCV vaccination which is still under investigation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 10829942     DOI: 10.1007/bf02825113

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  37 in total

1.  Hepatitis B immune globulin (HBIG) efficacy in the interruption of perinatal transmission of hepatitis B virus carrier state. Initial report of a randomised double-blind placebo-controlled trial.

Authors:  R P Beasley; L Y Hwang; C C Lin; C E Stevens; K Y Wang; T S Sun; F J Hsieh; W Szmuness
Journal:  Lancet       Date:  1981-08-22       Impact factor: 79.321

2.  Cellular immune response to HBcAg in mother-to-infant transmission of hepatitis B virus.

Authors:  H Y Hsu; M H Chang; K H Hsieh; C Y Lee; H H Lin; L H Hwang; P J Chen; D S Chen
Journal:  Hepatology       Date:  1992-05       Impact factor: 17.425

3.  Long term clinical and virologic outcome of primary hepatitis C virus infection in children: a prospective study.

Authors:  M H Chang; Y H Ni; L H Hwang; K H Lin; H H Lin; P J Chen; C Y Lee; D S Chen
Journal:  Pediatr Infect Dis J       Date:  1994-09       Impact factor: 2.129

4.  Hepatitis B virus integration in hepatitis B virus-related hepatocellular carcinoma in childhood.

Authors:  M H Chang; P J Chen; J Y Chen; M Y Lai; H C Hsu; D C Lian; Y G Liu; D S Chen
Journal:  Hepatology       Date:  1991-02       Impact factor: 17.425

5.  Postnatal infectivity of hepatitis B surface antigen-carrier mothers.

Authors:  R P Beasley; L Y Hwang
Journal:  J Infect Dis       Date:  1983-02       Impact factor: 5.226

6.  Possible role of high-titer maternal viremia in perinatal transmission of hepatitis C virus.

Authors:  H H Lin; J H Kao; H Y Hsu; Y H Ni; S H Yeh; L H Hwang; M H Chang; S C Hwang; P J Chen; D S Chen
Journal:  J Infect Dis       Date:  1994-03       Impact factor: 5.226

7.  Prevalence of hepatitis C in transfusion dependent thalassaemics & haemophilics.

Authors:  D K Bhattacharya; S Bhattacharjee; M De; P Lahiri
Journal:  Indian J Med Res       Date:  1991-12       Impact factor: 2.375

8.  Prevalence of hepatitis C virus infection in asymptomatic anti-HIV1 negative pregnant women and their children.

Authors:  P Marcellin; J Bernuau; M Martinot-Peignoux; D Larzul; L Z Xu; S Tran; A Bezeaud; M C Guimont; M Levardon; P Aumont
Journal:  Dig Dis Sci       Date:  1993-12       Impact factor: 3.199

9.  Transmission of hepatitis C virus from mothers to infants. The Vertical Transmission of Hepatitis C Virus Collaborative Study Group.

Authors:  H Ohto; S Terazawa; N Sasaki; N Sasaki; K Hino; C Ishiwata; M Kako; N Ujiie; C Endo; A Matsui
Journal:  N Engl J Med       Date:  1994-03-17       Impact factor: 91.245

10.  Baseline seroepidemiology of hepatitis B virus infection in children in Taipei, 1984: a study just before mass hepatitis B vaccination program in Taiwan.

Authors:  H Y Hsu; M H Chang; D S Chen; C Y Lee; J L Sung
Journal:  J Med Virol       Date:  1986-04       Impact factor: 2.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.